Karla Bordon is a pharmacist and biochemist with a PhD in Toxicology and over two decades of experience in experimental and translational toxinology. Her research focuses on bioactive biomolecules, venom-derived peptides and enzymes, preclinical models, and translational strategies for bioactive compounds and biopharmaceuticals. She has strong expertise in protein biochemistry, chromatographic purification, enzymatic characterization, venomics, mass spectrometry, and experimental toxicology, with emphasis on reproducibility, data curation, and translational applicability. During her doctoral training, she identified and characterized the enzymes bordonein-L (UniProt C0HJE7) and hyaluronidase CdtHya1 (B3EWP2), contributing to the biotechnological potential of venom-derived molecules. Her career includes postdoctoral training, leadership roles in multidisciplinary and international research networks, and participation in projects funded by FAPESP, CNPq and FAPESP/FNRS. Ad hoc reviewer for Swiss National Science Foundation (SNSF).She also has experience in quality management, regulatory decision-making, public health services, and university–industry interaction, supporting a systemic view of health innovation. Currently, she is a Senior Researcher in Toxinology at the University of São Paulo (USP), integrating research support, project development, and advanced training, with the mission of bridging basic science, innovation, and public health through translational research.